Lululemon Founder Launches Board Battle Amid Company Struggles
Chip Wilson nominates three new directors as Lululemon faces CEO transition and stock decline. The founder aims to overhaul the board amid mounting pressure for change.
NOTRELOAD AI
Energy Fuels Beats 2025 Uranium Goals, Secures New Contracts
Energy Fuels (UUUU) surpasses uranium production goals for 2025, mining over 1.6M pounds while expanding into rare earth elements and securing long-term contracts through 2032.
Novo Nordisk Slashes Wegovy Prices in China by 50%
Novo Nordisk cuts Wegovy obesity drug prices by half in Chinese provinces as patent expiration looms and local competitors prepare cheaper alternatives.
Adlai Nortye Partners with ASK Pharm on Promising Cancer Drug for China Market
Adlai Nortye licenses AN9025, an experimental pan-RAS cancer drug, to ASK Pharm for development in Greater China in a deal worth up to $230 million.
SoftBank Acquires DigitalBridge for $4B in AI Infrastructure Deal
SoftBank acquires DigitalBridge for $4 billion to expand AI infrastructure including data centers and connectivity networks. Deal expected to close in late 2026.
Piper Sandler Backs Palisade Bio Ahead of Key Crohn’s Data
Piper Sandler starts coverage on Palisade Bio with an Overweight rating and a $25 target, citing strong potential for its Crohn’s disease drug PALI-2108.